At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Lactones; Macrocyclic compounds; Spongistatins
- Mechanism of Action Mitosis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 17 Apr 1997 No-Development-Reported for Cancer in USA (Unknown route)
- 10 Oct 1995 This is a new profile.
- 10 Oct 1995 Preclinical development for Cancer in USA (Unknown route)